France allowed the Pasteur institute to fail - a much desired vaccine was stopped because it wasn't effective enough. Impossible to imagine the same happening in Russia, as Putin needs to project power.
Do you know if there are more trials underway to verify this? I'm guessing it ties in to AZ's encouragement for delaying the second dose i.e. wait until the immune response has died down. I think UK medical consensus is currently recommending 12 weeks rather than the original 3-4.
But what use is that when the availability of the vaccine will remain so limited for the foreseeable future? When the producers are unable to deliver what they have agreed to – or can only deliver much later?"
Personally, I blame part of the availability issues, caused by the Pfizer plant "shutdown" in Belgium, on that hatchet job. The Spiegel was among the first to use the unsatisfactory vaccine availability against von der Leyen. Fair enough, but as solution they called for increased ordering. Pressure built, frustration kicked in and then every news outlet demanded the same thing. Local politicians supported that narrative, they avoided discussions about their own fuck ups. Then the EU ordered more, demand exceeded capacity, and Pfizer reworks its plant. That resulted in even worse short term availability issues. So great job, I guess.
In terms of effect on effectiveness per person it is purely speculative.
Exploratory analyses showed that increased immunogenicity was associated with a longer dose interval (see Immunogenicity Table 3). Efficacy is currently demonstrated with more certainty for dose intervals from 8 to 12 weeks. Data for intervals longer than 12 weeks are limited.
https://www.gov.uk/government/publications/regulatory-approv...
As such the decision was very clearly made on the basis of getting more people some protection, whether or not they could be confident of the effect of the long term protection across the various vaccines.0
It's a reasonable gamble to take given the amount of spread, and is not a criticism (though the way the change was communicated was absolutely awful), but if it had been a decision taken based on available data one would expect the schedules actually tested by the manufacturers to be adhered to, even if different between the vaccine.
This is based on the theory that the immune system response to Oxford's virus vector is mostly negating the benefit of the second dose taken 21 days after the first. Gam-COVID-Vac gets around this by using different viruses for each dose, and has 90% efficacy results from their Phase III trial. Unfortunately, no one can yet manufacture it in anything like bulk quantities, but they have set up manufacturing partnerships with a whole bunch of countries from India to South Korea.